Hosseinipour, M.C., Innes, C., Naidoo, S., Mann, P., Hutter, J., Ramjee, G., Sebe, M., Maganga, L., Herce, M.E., DeCamp, A.C. and Marshall, K., 2021. Phase 1 Human Immunodeficiency Virus (HIV) vaccine trial to evaluate the safety and immunogenicity of HIV Subtype C DNA and MF59-adjuvanted subtype C envelope protein. Clinical Infectious Diseases, 72(1), pp.50-60.
Phase 1 Human Immunodeficiency Virus (HIV) vaccine trial to evaluate the safety and immunogenicity of HIV Subtype C DNA and MF59-adjuvanted subtype C envelope protein.
- Journal Articles
